Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITONAVIR vs RIZATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITONAVIR vs RIZATRIPTAN: Safety Overview

Metric RITONAVIR RIZATRIPTAN
Total FAERS Reports 11,980 2,896
Deaths Reported 1,190 68
Death Rate 9.9% 2.3%
Hospitalizations 2,925 479
Average Patient Age 43.8 yrs 44.6 yrs
% Female Patients 43.8% 77.2%
FDA Approval Date Dec 3, 2020 Apr 14, 2023
Manufacturer AbbVie Inc. Panacea Biotec Limited
Route ORAL ORAL
Marketing Status Discontinued Discontinued